Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Streptococcal toxic shock syndrome caused by β-hemolytic streptococci: Clinical features and cytokine and chemokine analyses of 15 cases.

Yoshizawa S, Matsumura T, Ikebe T, Ichibayashi R, Fukui Y, Satoh T, Tsubota T, Honda M, Ishii Y, Tateda K, Ato M.

J Infect Chemother. 2019 Feb 7. pii: S1341-321X(19)30021-2. doi: 10.1016/j.jiac.2019.01.006. [Epub ahead of print]

PMID:
30744988
2.

Efficient protection of mice from influenza A/H1N1pdm09 virus challenge infection via high avidity serum antibodies induced by booster immunizations with inactivated whole virus vaccine.

Sato K, Takahashi Y, Adachi Y, Asanuma H, Ato M, Tashiro M, Itamura S.

Heliyon. 2019 Jan 3;5(1):e01113. doi: 10.1016/j.heliyon.2018.e01113. eCollection 2019 Jan.

3.

Clinico-microbiological analysis of 121 patients with pulmonary Mycobacteroides abscessus complex disease in Japan - An NTM-JRC study with RIT.

Morimoto K, Nakagawa T, Asami T, Morino E, Fujiwara H, Hase I, Tsujimoto Y, Izumi K, Hayashi Y, Matsuda S, Murase Y, Yano R, Takasaki J, Betsuyaku T, Aono A, Goto H, Nishimura T, Sasaki Y, Hoshino Y, Kurashima A, Ato M, Ogawa K, Hasegawa N, Mitarai S.

Respir Med. 2018 Dec;145:14-20. doi: 10.1016/j.rmed.2018.10.012. Epub 2018 Oct 17.

PMID:
30509703
4.

Discrimination of Mycobacterium leprae and Mycobacterium haemophilum in Clinical Isolates and Specimens by Multiplex PCR Assay and Prediction of Drug Susceptibility.

Kitaoka N, Fukano H, Yoshida M, Miyamoto Y, Mori S, Ishii N, Ato M, Ohara N, Hoshino Y.

J Clin Microbiol. 2019 Jan 30;57(2). pii: e01760-18. doi: 10.1128/JCM.01760-18. Print 2019 Feb. No abstract available.

PMID:
30463891
5.

A rapid and non-pathogenic assay for association of Mycobacterium tuberculosis gyrBA mutations and fluoroquinolone resistance using recombinant Mycobacterium smegmatis.

Yoshida M, Nakata N, Miyamoto Y, Fukano H, Ato M, Hoshino Y.

FEMS Microbiol Lett. 2018 Dec 1;365(23). doi: 10.1093/femsle/fny266.

PMID:
30418577
6.

Lipoteichoic acid anchor triggers Mincle to drive protective immunity against invasive group A Streptococcus infection.

Imai T, Matsumura T, Mayer-Lambertz S, Wells CA, Ishikawa E, Butcher SK, Barnett TC, Walker MJ, Imamura A, Ishida H, Ikebe T, Miyamoto T, Ato M, Ohga S, Lepenies B, van Sorge NM, Yamasaki S.

Proc Natl Acad Sci U S A. 2018 Nov 6;115(45):E10662-E10671. doi: 10.1073/pnas.1809100115. Epub 2018 Oct 23.

PMID:
30352847
7.

Epidemiology of Adults and Children Treated for Nontuberculous Mycobacterial Pulmonary Disease in Japan.

Izumi K, Morimoto K, Hasegawa N, Uchimura K, Kawatsu L, Ato M, Mitarai S.

Ann Am Thorac Soc. 2018 Oct 19. doi: 10.1513/AnnalsATS.201806-366OC. [Epub ahead of print]

PMID:
30339468
8.

A Collaborative Study to Establish the Second Korean National Reference Standard for Snake Venom.

Han K, Jung K, Oh H, Song H, Park S, Kim JH, Min G, Lee BH, Nam HS, Kim YJ, Ato M, Jeong J, Ahn C.

Toxicol Res. 2018 Jul;34(3):191-197. doi: 10.5487/TR.2018.34.3.191. Epub 2018 Jul 15.

9.

Sample size estimation for heterogeneous growth curve models with attrition.

Vallejo G, Ato M, Fernández MP, Livacic-Rojas PE.

Behav Res Methods. 2018 Jun 22. doi: 10.3758/s13428-018-1059-y. [Epub ahead of print]

PMID:
29934696
10.

Introduction of Human Flt3-L and GM-CSF into Humanized Mice Enhances the Reconstitution and Maturation of Myeloid Dendritic Cells and the Development of Foxp3+CD4+ T Cells.

Iwabuchi R, Ikeno S, Kobayashi-Ishihara M, Takeyama H, Ato M, Tsunetsugu-Yokota Y, Terahara K.

Front Immunol. 2018 May 28;9:1042. doi: 10.3389/fimmu.2018.01042. eCollection 2018.

11.

HIV LTR-Driven Antisense RNA by Itself Has Regulatory Function and May Curtail Virus Reactivation From Latency.

Kobayashi-Ishihara M, Terahara K, Martinez JP, Yamagishi M, Iwabuchi R, Brander C, Ato M, Watanabe T, Meyerhans A, Tsunetsugu-Yokota Y.

Front Microbiol. 2018 May 25;9:1066. doi: 10.3389/fmicb.2018.01066. eCollection 2018.

12.

Naturally occurring a loss of a giant plasmid from Mycobacterium ulcerans subsp. shinshuense makes it non-pathogenic.

Nakanaga K, Ogura Y, Toyoda A, Yoshida M, Fukano H, Fujiwara N, Miyamoto Y, Nakata N, Kazumi Y, Maeda S, Ooka T, Goto M, Tanigawa K, Mitarai S, Suzuki K, Ishii N, Ato M, Hayashi T, Hoshino Y.

Sci Rep. 2018 May 29;8(1):8218. doi: 10.1038/s41598-018-26425-1.

13.

Freeze-dried equine-derived redback spider antivenom: a local irritation study by intramuscular injection in rabbits and a repeated-dose toxicity study in rats.

Yamamoto A, Harano S, Shinya N, Nagano A, Miyatsu Y, Sawabe K, Matsumura T, Ato M, Takahashi M, Taki H, Hifumi T.

J Toxicol Pathol. 2018 Apr;31(2):105-112. doi: 10.1293/tox.2017-0053. Epub 2018 Feb 19.

14.

Development of a Simple Permeability Assay Method for Snake Venom-induced Vascular Damage.

Sato K, Kodama A, Kase C, Hirakawa S, Ato M.

Anal Sci. 2018;34(3):323-327. doi: 10.2116/analsci.34.323.

15.

Venom and Antivenom of the Redback Spider (Latrodectus hasseltii) in Japan. Part I. Venom Extraction, Preparation, and Laboratory Testing.

Matsumura T, Mashiko R, Sato T, Itokawa K, Maekawa Y, Ogawa K, Isawa H, Yamamoto A, Mori S, Horita A, Ginnaga A, Miyatsu Y, Takahashi M, Taki H, Hifumi T, Sawabe K, Ato M.

Jpn J Infect Dis. 2018 Mar 22;71(2):116-121. doi: 10.7883/yoken.JJID.2017.291. Epub 2018 Feb 28.

16.

Distorted antibody repertoire developed in the absence of pre-B cell receptor formation.

Sun L, Kono N, Shimizu T, Toh H, Xue H, Numata O, Ato M, Itamura S, Ohnishi K.

Biochem Biophys Res Commun. 2018 Jan 1;495(1):1411-1417. doi: 10.1016/j.bbrc.2017.11.171. Epub 2017 Nov 27.

17.

Comparative Study of Biological Activities of Venom from Colubrid Snakes Rhabdophis tigrinus (Yamakagashi) and Rhabdophis lateralis.

Komori Y, Hifumi T, Yamamoto A, Sakai A, Ato M, Sawabe K, Nikai T.

Toxins (Basel). 2017 Nov 17;9(11). pii: E373. doi: 10.3390/toxins9110373.

18.

Venom and Antivenom of the Redback Spider (Latrodectus hasseltii) in Japan. Part II. Experimental Production of Equine Antivenom against the Redback Spider.

Mori S, Horita A, Ginnaga A, Miyatsu Y, Sawabe K, Matsumura T, Ato M, Yamamoto A, Shibayama K, Arai S, Yamagishi T, Takahashi M, Taki H, Hifumi T.

Jpn J Infect Dis. 2017 Nov 22;70(6):635-641. doi: 10.7883/yoken.JJID.2017.125. Epub 2017 Oct 31.

19.

Characterization of novel monoclonal antibodies against the MERS-coronavirus spike protein and their application in species-independent antibody detection by competitive ELISA.

Fukushi S, Fukuma A, Kurosu T, Watanabe S, Shimojima M, Shirato K, Iwata-Yoshikawa N, Nagata N, Ohnishi K, Ato M, Melaku SK, Sentsui H, Saijo M.

J Virol Methods. 2018 Jan;251:22-29. doi: 10.1016/j.jviromet.2017.10.008. Epub 2017 Oct 6.

PMID:
28993122
20.

Population Structure and Local Adaptation of MAC Lung Disease Agent Mycobacterium avium subsp. hominissuis.

Yano H, Iwamoto T, Nishiuchi Y, Nakajima C, Starkova DA, Mokrousov I, Narvskaya O, Yoshida S, Arikawa K, Nakanishi N, Osaki K, Nakagawa I, Ato M, Suzuki Y, Maruyama F.

Genome Biol Evol. 2017 Sep 1;9(9):2403-2417. doi: 10.1093/gbe/evx183.

21.

Mycobacterial DNA-binding protein 1 is critical for long term survival of Mycobacterium smegmatis and simultaneously coordinates cellular functions.

Enany S, Yoshida Y, Tateishi Y, Ozeki Y, Nishiyama A, Savitskaya A, Yamaguchi T, Ohara Y, Yamamoto T, Ato M, Matsumoto S.

Sci Rep. 2017 Jul 28;7(1):6810. doi: 10.1038/s41598-017-06480-w.

22.

A critical role of Gas6/Axl signal in allergic airway responses during RSV vaccine-enhanced disease.

Shibata T, Ato M.

Immunol Cell Biol. 2017 Nov;95(10):906-915. doi: 10.1038/icb.2017.61. Epub 2017 Jul 19.

PMID:
28722020
23.

Adaptive B Cell Responses to Influenza Virus Infection in the Lung.

Takahashi Y, Onodera T, Adachi Y, Ato M.

Viral Immunol. 2017 Jul/Aug;30(6):431-437. doi: 10.1089/vim.2017.0025. Epub 2017 Jun 29. Review.

PMID:
28661720
24.

A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines.

Wada Y, Nithichanon A, Nobusawa E, Moise L, Martin WD, Yamamoto N, Terahara K, Hagiwara H, Odagiri T, Tashiro M, Lertmemongkolchai G, Takeyama H, Groot AS, Ato M, Takahashi Y.

Sci Rep. 2017 Apr 28;7(1):1283. doi: 10.1038/s41598-017-01372-5.

25.

Clinical Serum Therapy: Benefits, Cautions, and Potential Applications.

Hifumi T, Yamamoto A, Ato M, Sawabe K, Morokuma K, Morine N, Kondo Y, Noda E, Sakai A, Takahashi J, Umezawa K.

Keio J Med. 2017 Dec 25;66(4):57-64. doi: 10.2302/kjm.2016-0017-IR. Epub 2017 Apr 28. Review.

26.

Simian Immunodeficiency Virus Targeting of CXCR3+ CD4+ T Cells in Secondary Lymphoid Organs Is Associated with Robust CXCL10 Expression in Monocyte/Macrophage Subsets.

Fujino M, Sato H, Okamura T, Uda A, Takeda S, Ahmed N, Shichino S, Shiino T, Saito Y, Watanabe S, Sugimoto C, Kuroda MJ, Ato M, Nagai Y, Izumo S, Matsushima K, Miyazawa M, Ansari AA, Villinger F, Mori K.

J Virol. 2017 Jun 9;91(13). pii: e00439-17. doi: 10.1128/JVI.00439-17. Print 2017 Jul 1.

27.

Deciphering antigen-responding antibody repertoires by using next-generation sequencing and confirming them through antibody-gene synthesis.

Kono N, Sun L, Toh H, Shimizu T, Xue H, Numata O, Ato M, Ohnishi K, Itamura S.

Biochem Biophys Res Commun. 2017 May 27;487(2):300-306. doi: 10.1016/j.bbrc.2017.04.054. Epub 2017 Apr 12.

28.

Boosting of post-exposure human T-cell and B-cell recall responses in vivo by Burkholderia pseudomallei-related proteins.

Nithichanon A, Gourlay LJ, Bancroft GJ, Ato M, Takahashi Y, Lertmemongkolchai G.

Immunology. 2017 May;151(1):98-109. doi: 10.1111/imm.12709. Epub 2017 Feb 9.

29.

Dual antiplasmodial activity of vitamin D3 and its analog, 22-oxacalcitriol, by direct and indirect mechanisms.

Yamamoto K, Iwagami M, Seki T, Kano S, Ota N, Ato M.

Parasitol Int. 2017 Apr;66(2):89-99. doi: 10.1016/j.parint.2016.11.015. Epub 2016 Dec 2.

30.

A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013.

Morimoto K, Hasegawa N, Izumi K, Namkoong H, Uchimura K, Yoshiyama T, Hoshino Y, Kurashima A, Sokunaga J, Shibuya S, Shimojima M, Ato M, Mitarai S.

Ann Am Thorac Soc. 2017 Jan;14(1):49-56. doi: 10.1513/AnnalsATS.201607-573OC.

PMID:
27788025
31.

Glibenclamide impairs responses of neutrophils against Burkholderia pseudomallei by reduction of intracellular glutathione.

Kewcharoenwong C, Rinchai D, Nithichanon A, Bancroft GJ, Ato M, Lertmemongkolchai G.

Sci Rep. 2016 Oct 7;6:34794. doi: 10.1038/srep34794.

32.

Power analysis to detect treatment effect in longitudinal studies with heterogeneous errors and incomplete data.

Vallejo G, Ato M, Fernández García P, Livacic Rojas PE, Tuero Herrero E.

Psicothema. 2016 Aug;28(3):330-9. doi: 10.7334/psicothema2016.92.

PMID:
27448269
33.

Spontaneous mutations in Streptococcus pyogenes isolates from streptococcal toxic shock syndrome patients play roles in virulence.

Ikebe T, Matsumura T, Nihonmatsu H, Ohya H, Okuno R, Mitsui C, Kawahara R, Kameyama M, Sasaki M, Shimada N, Ato M, Ohnishi M.

Sci Rep. 2016 Jun 28;6:28761. doi: 10.1038/srep28761.

34.

Epidemiology of Pulmonary Nontuberculous Mycobacterial Disease, Japan(1).

Namkoong H, Kurashima A, Morimoto K, Hoshino Y, Hasegawa N, Ato M, Mitarai S.

Emerg Infect Dis. 2016 Jun;22(6):1116-7. doi: 10.3201/eid2206.151086. No abstract available.

35.

Whole-Virion Influenza Vaccine Recalls an Early Burst of High-Affinity Memory B Cell Response through TLR Signaling.

Onodera T, Hosono A, Odagiri T, Tashiro M, Kaminogawa S, Okuno Y, Kurosaki T, Ato M, Kobayashi K, Takahashi Y.

J Immunol. 2016 May 15;196(10):4172-84. doi: 10.4049/jimmunol.1600046. Epub 2016 Apr 6.

36.

Microcirculation-on-a-Chip: A Microfluidic Platform for Assaying Blood- and Lymphatic-Vessel Permeability.

Sato M, Sasaki N, Ato M, Hirakawa S, Sato K, Sato K.

PLoS One. 2015 Sep 2;10(9):e0137301. doi: 10.1371/journal.pone.0137301. eCollection 2015.

37.

Distinct germinal center selection at local sites shapes memory B cell response to viral escape.

Adachi Y, Onodera T, Yamada Y, Daio R, Tsuiji M, Inoue T, Kobayashi K, Kurosaki T, Ato M, Takahashi Y.

J Exp Med. 2015 Sep 21;212(10):1709-23. doi: 10.1084/jem.20142284. Epub 2015 Aug 31.

38.

Macroautophagy is essential for killing of intracellular Burkholderia pseudomallei in human neutrophils.

Rinchai D, Riyapa D, Buddhisa S, Utispan K, Titball RW, Stevens MP, Stevens JM, Ogawa M, Tanida I, Koike M, Uchiyama Y, Ato M, Lertmemongkolchai G.

Autophagy. 2015;11(5):748-55. doi: 10.1080/15548627.2015.1040969.

39.

Venomous snake bites: clinical diagnosis and treatment.

Hifumi T, Sakai A, Kondo Y, Yamamoto A, Morine N, Ato M, Shibayama K, Umezawa K, Kiriu N, Kato H, Koido Y, Inoue J, Kawakita K, Kuroda Y.

J Intensive Care. 2015 Apr 1;3(1):16. doi: 10.1186/s40560-015-0081-8. eCollection 2015. Review.

40.

Humanized mice dually challenged with R5 and X4 HIV-1 show preferential R5 viremia and restricted X4 infection of CCR5(+)CD4(+) T cells.

Terahara K, Ishige M, Ikeno S, Okada S, Kobayashi-Ishihara M, Ato M, Tsunetsugu-Yokota Y.

Microbes Infect. 2015 May;17(5):378-86. doi: 10.1016/j.micinf.2015.02.002. Epub 2015 Apr 1.

PMID:
25839960
41.

Programmed death ligand 1 on Burkholderia pseudomallei-infected human polymorphonuclear neutrophils impairs T cell functions.

Buddhisa S, Rinchai D, Ato M, Bancroft GJ, Lertmemongkolchai G.

J Immunol. 2015 May 1;194(9):4413-21. doi: 10.4049/jimmunol.1402417. Epub 2015 Mar 23.

42.

Update of antivenom supply for redback spider bites in Japan.

Hifumi T, Taki H, Yamamoto A, Ato M, Koido Y, Kuroda Y.

J Intensive Care. 2015 Feb 11;3(1):7. doi: 10.1186/s40560-014-0070-3. eCollection 2015.

43.

Clinical characteristics of redback spider bites.

Hifumi T, Fujimi S, Yamagishi T, Arai S, Sawabe K, Yamamoto A, Ato M, Shibayama K, Ginnaga A, Kiriu N, Kato H, Koido Y, Inoue J, Kishikawa M, Abe Y, Kawakita K, Hagiike M, Kuroda Y.

J Intensive Care. 2014 Nov 2;2(1):62. doi: 10.1186/s40560-014-0062-3. eCollection 2014.

44.

BILL-cadherin/cadherin-17 contributes to the survival of memory B cells.

Funakoshi S, Shimizu T, Numata O, Ato M, Melchers F, Ohnishi K.

PLoS One. 2015 Jan 22;10(1):e0117566. doi: 10.1371/journal.pone.0117566. eCollection 2015.

45.

Effect of antivenom therapy of Rhabdophis tigrinus (Yamakagashi snake) bites.

Hifumi T, Sakai A, Yamamoto A, Murakawa M, Ato M, Shibayama K, Kato H, Koido Y, Inoue J, Abe Y, Kawakita K, Hagiike M, Ginnaga A, Kuroda Y.

J Intensive Care. 2014 Jul 31;2(1):44. doi: 10.1186/s40560-014-0044-5. eCollection 2014.

46.

Rhabdophis tigrinus is not a pit viper but its bites result in venom-induced consumptive coagulopathy similar to many viper bites.

Silva A, Hifumi T, Sakai A, Yamamoto A, Murakawa M, Ato M, Shibayama K, Ginnaga A, Kato H, Koido Y, Inoue J, Abe Y, Kawakita K, Hagiike M, Kuroda Y.

J Intensive Care. 2014 Jul 31;2(1):43. doi: 10.1186/s40560-014-0043-6. eCollection 2014.

47.

Epitope mapping of the hemagglutinin molecule of A/(H1N1)pdm09 influenza virus by using monoclonal antibody escape mutants.

Matsuzaki Y, Sugawara K, Nakauchi M, Takahashi Y, Onodera T, Tsunetsugu-Yokota Y, Matsumura T, Ato M, Kobayashi K, Shimotai Y, Mizuta K, Hongo S, Tashiro M, Nobusawa E.

J Virol. 2014 Nov;88(21):12364-73. doi: 10.1128/JVI.01381-14. Epub 2014 Aug 13.

48.

Potentially fatal coagulopathy secondary to yamakagashi (Rhabdophis tigrinus) bites that completely recovered with antivenom treatment.

Hifumi T, Murakawa M, Sakai A, Ginnaga A, Yamamoto A, Ato M, Kato H, Koido Y, Kawakita K, Hagiike M, Kuroda Y.

Acute Med Surg. 2014 Aug 8;2(2):123-126. doi: 10.1002/ams2.69. eCollection 2015 Apr.

49.

Broad cross-reactive epitopes of the H5N1 influenza virus identified by murine antibodies against the A/Vietnam/1194/2004 hemagglutinin.

Kobayashi-Ishihara M, Takahashi H, Ohnishi K, Nishimura K, Terahara K, Ato M, Itamura S, Kageyama T, Tsunetsugu-Yokota Y.

PLoS One. 2014 Jun 19;9(6):e99201. doi: 10.1371/journal.pone.0099201. eCollection 2014.

50.

Enrichment of amino acid-oxidizing, acetate-reducing bacteria.

Ato M, Ishii M, Igarashi Y.

J Biosci Bioeng. 2014 Aug;118(2):160-5. doi: 10.1016/j.jbiosc.2014.02.003. Epub 2014 Mar 11.

PMID:
24630616

Supplemental Content

Support Center